dc.contributorUniversity of Sorocaba (UNISO)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-12-11T17:30:12Z
dc.date.available2018-12-11T17:30:12Z
dc.date.created2018-12-11T17:30:12Z
dc.date.issued2016-01-01
dc.identifierAdvanced Pharmaceutical Bulletin, v. 6, n. 3, p. 443-447, 2016.
dc.identifier2251-7308
dc.identifier2228-5881
dc.identifierhttp://hdl.handle.net/11449/178418
dc.identifier10.15171/apb.2016.057
dc.identifier2-s2.0-84995640064
dc.description.abstractPurpose: Betulin is a pentacyclic triterpene found in the outer barks of innumerous plants. This secondary metabolite is easily isolated from plants with the major interest in converting it to betulinic acid, which pharmacological properties were much more exploited than betulin. But, investments in the own betulin have been grown since no chemical step is necessary. In this study we focused the precursor betulin in order to evaluate its mutagenicity by Salmonella/microsome assay (Ames test). Methods: The Ames test was carried out using a commercial betulin exposed to Salmonella typhimurium strains TA98, TA100, TA102, and TA97a, in experiments with (+S9) and without (-S9) metabolic activation. Results: Betulin was unable to increase the number of revertants (+S9 and -S9 metabolic activation) showing the absence of any mutagenic effect by Ames test. Conclusion: This study allowed attribute safety to betulin being important for exploiting its pharmacological uses.
dc.languageeng
dc.relationAdvanced Pharmaceutical Bulletin
dc.relation0,632
dc.relation0,632
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectAmes test
dc.subjectBetulin
dc.subjectSalmonella mutagenicity
dc.subjectTriterpenoid
dc.titleEvaluation of betulin mutagenicity by Salmonella/microsome test
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución